SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827809-18-000040
Filing Date
2018-11-13
Accepted
2018-11-09 17:32:43
Documents
73
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nvln-093018x10q.htm   iXBRL 10-Q 1307707
2 EXHIBIT 10.3 a20180930exhibit103.htm EX-10.3 722985
3 EXHIBIT 31.1 a20180930exhibit311.htm EX-31.1 12379
4 EXHIBIT 31.2 a20180930exhibit312.htm EX-31.2 12366
5 EXHIBIT 32.1 a20180930exhibit321.htm EX-32.1 6032
6 EXHIBIT 32.2 a20180930exhibit322.htm EX-32.2 6148
  Complete submission text file 0000827809-18-000040.txt   6439222

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvln-20180930.xsd EX-101.SCH 39968
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvln-20180930_cal.xml EX-101.CAL 71804
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvln-20180930_def.xml EX-101.DEF 186573
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvln-20180930_lab.xml EX-101.LAB 462267
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvln-20180930_pre.xml EX-101.PRE 303170
12 EXTRACTED XBRL INSTANCE DOCUMENT nvln-093018x10q_htm.xml XML 955691
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 181174240
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1